Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Leukemia, Lymphocytic, Chronic, B-Cell 1

Interventions

Specimen Handling 327Magnetic Resonance Spectroscopy 278pembrolizumab 268Carboplatin 190Cyclophosphamide 187Biopsy 183Cisplatin 163Gemcitabine 138Paclitaxel 137Bevacizumab 124fludarabine 122Nivolumab 119Radiotherapy 116Oxaliplatin 94venetoclax 92Docetaxel 90Fluorouracil 89Capecitabine 89Dexamethasone 86Drug Therapy 77Pemetrexed 75Rituximab 74Leucovorin 72durvalumab 71Blood Specimen Collection 70Radiosurgery 69Standard of Care 68atezolizumab 67Doxorubicin 66Radiation 63

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Pneumococcal Vaccines × 90 days × Clear all
NCT05183854 2026-04-09

Pneumococcal Pneumonia Vaccine Series (PCV20 and PPSV23) in Patients With Chronic Lymphocytic Leukemia Associated Immunodeficiency, PROTECT CLL Trial

University of Utah

Phase 2 Recruiting
61 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Lymphocytic, Chronic, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡